Summary by Futu AI
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a stock grant transaction on September 30, 2024. Vittiglio acquired 50,000 shares of bluebird bio's common stock at no cost. Following this transaction, he now directly holds a total of 94,783 shares in the company. The transaction, which involved common stock, was executed as part of a grant, typically awarded as a form of compensation or incentive.